The Bioresearch Monitoring (BIMO) Program, operated by the U.S. Food and Drug Administration (FDA), conducts on-site inspections and data audits in order to effectively monitor the compliance of ...

The BIMO program was established to assure the quality and integrity of data submitted to the agency in support of new product approvals and marketing applications. This is separate from the ...

announces today that it recently underwent an extensive 5-day high priority Bioresearch Monitoring Program (BIMO) inspection by the U.S. Food and Drug Administration (FDA) Center for Drug ...